Automated Breast Ultrasound Market (2026 - 2033)

Automated Breast Ultrasound Market Summary

The global automated breast ultrasound market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.7 billion in 2026 to USD 7.3 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing prevalence of breast cancer owing to a rise in sedentary lifestyles, obesity, changes in eating habits, and rising alcohol consumption is expected to increase the risk of the disease. In addition, the demand for reliable identification of breast lesions in the early stage of cancer is encouraging major manufacturing companies to develop automated diagnosis methods. Furthermore, various other government initiatives and awareness programs are significant contributors to the growth of the market.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to a report from the American Cancer Society, approximately 2.04 million people were diagnosed with cancer in 2025. In addition, a report published by the WHO in February 2025 noted about 3.2 million cases of breast cancer and 1.1 million deaths worldwide in 2024. The increase in breast cancer cases highlights the need for technologically advanced medical devices that facilitate easier and earlier detection compared to conventional methods. This demand is expected to drive growth in the market over the forecast period.

The survival rate for breast cancer is significantly higher when diagnosed in the early stages; however, it drops to around 25 percent when detected at later stages. An article from the Massachusetts Institute of Technology, published in July 2023, reported that MIT researchers have designed a wearable ultrasound device capable of detecting tumors at an early stage. Such technological advancements are likely to boost market growth further in the coming years.

Various initiatives by government institutions and companies have raised awareness about breast cancer among both men and women, positively impacting market growth. For example, the WHO launched a new roadmap for breast cancer to save 2.5 million lives from the disease by 2040. Similarly, the Ministry of Health and Family Welfare in India is providing financial assistance to individuals living below the poverty line who are suffering from diseases such as cancer through the Umbrella Scheme, Rashtriya Arogya Nidhi, and the Health Minister’s Discretionary Grant.

Analyst Perspective

The global market for automated breast ultrasound is expected to experience considerable growth over the forecast period. This growth is driven by the increase in the incidence rate of breast cancer, coupled with the need for advanced technologies for early detection of the disease. Increased awareness of the benefits of early detection of breast cancer has fueled the adoption of the automated breast ultrasound market. The high cost of advanced imaging equipment and its inaccessibility in remote regions, mostly in developing countries, may hinder the growth of this market. Major opportunities are emerging from ongoing technological advancements, growing investments in breast cancer screening, and government policies aimed at enhancing breast cancer care and treatment.

Product Insights

Automated breast ultrasound dominated the market, accounting for over 60.0% market share in 2025. The growth can be attributed to the user-friendly features of the device, its availability, and technological advancements. In addition, automated breast ultrasound provides comprehensive breast imaging, aiding early detection, especially in dense breast tissue. It uses three-dimensional imaging techniques, which improve visualization and aid in accurate early detection. Thereby boosting the market growth. For instance, according to an article by GE Healthcare published in October 2023, the use of Invenia ABUS 2.0 has helped detect breast cancer with more accuracy. It can be attributed to the latest 3D ultrasound innovations and AI-based solutions, which helps radiologists in thoroughly reviewing all layers of dense tissue to identify breast cancers, particularly small invasive cancers that are often missed by mammography.

The automated breast volume scanner is expected to grow at a significant CAGR during the forecast period. The segment growth can be attributed to the growing demand for automated solutions for early cancer detection. It can help bridge the radiology shortage by providing consistent, accurate results without requiring extensive operator expertise. Furthermore, the rising demand for advanced technological products for better diagnosis is anticipated to impede the segment growth. For instance, in February 2023, Abdul Latif Jameel Health partnered with iSono Health to introduce a portable 3D ultrasound breast imaging scanner that uses automated imaging and artificial intelligence.

End Use Insights

Hospitals dominated the market, accounting for around 50.0% of the market share in 2025. The segment growth can be attributed to the rising prevalence of breast cancer in recent times owing to a sedentary lifestyle. Hospitals are equipped with advanced diagnostic tools and staffed with skilled healthcare professionals, leading to more accurate cancer detection, thereby increasing patient footfall and boosting segment growth. For instance, in India, the Tata Trusts have the Tata Memorial Hospital in Mumbai, which helps address the burden of cancer. The trusts also launched an initiative to raise awareness about the critical importance of early detection of breast cancer, called “Gaanth Pe Dhyaan”.

Diagnostic imaging laboratories are expected to grow at the fastest CAGR during the forecast period. This growth can be attributed to the increasing number of diagnostic centers, the high prevalence of breast cancer, and the rising demand for imaging techniques for cancer treatment. All these factors have contributed to the segment growth over the forecast period.

Regional Insights

The North America automated breast ultrasound industry dominated the global market, with a revenue share of around 35.0% in 2025. This growth can be attributed to the increasing prevalence of breast cancer and the presence of key market players in this region. In addition, advanced healthcare infrastructure that supports early cancer detection, along with technological advancements and research and development, is a significant driver of market growth in this region. Furthermore, government initiatives, funding, and investment aimed at raising breast cancer awareness are boosting market growth over the forecast period.

To learn more about this report, Download Free Sample Report

U.S. Automated Breast Ultrasound Market Trends

The U.S. automated breast ultrasound industry dominated the global market, with a notable revenue share in 2025, owing to factors such as improved healthcare facilities and expenditure. Breast cancer is the second leading cause of cancer death. For instance, according to an article of the National Breast Cancer Coalition, in 2026, an estimated 321,910 women and 2,670 men in the U.S. are expected to be diagnosed with invasive breast cancer, and an additional 60,730 women with ductal carcinoma. In addition, the Cancer Moonshot is an initiative undertaken by the U.S. government to prevent more than 4 million cancer deaths by 2047 and improve the experience of people affected by cancer.

Europe Automated Breast Ultrasound Market Trends

Europe automated breast ultrasound industry was identified as a lucrative market in 2025. This market growth is attributed to the new technological advancements in this region. In addition, the growing prevalence of cancer, improved healthcare facilities, and focus on R&D have impacted the market growth. For instance, in October 2025, the European Health and Digital Executive Agency (HaDEA) published a report stating that there were about 374,800 new cases of breast cancer and 95,800 deaths from this disease in the European Union in 2022. The agency further announced new EU4Health initiatives to improve breast cancer diagnosis and treatment through imaging and digital technologies.

Asia Pacific Automated Breast Ultrasound Market Trends

The Asia Pacific automated breast ultrasound industry is anticipated to experience significant growth. The rising burden of breast cancer, leading to increased demand for innovative and technologically advanced cancer-detecting medical devices, is the major contributing factor for the market growth in this region. For instance, according to the Journal of the American Cancer Society published in January 2024, breast cancer deaths would increase to 61.7% by 2040 in the Southeast Asia region. In addition, an estimated 216,108 cases, accounting for 28.2% of all female cancers, occurred in India in 2022.

MEA Automated Breast Ultrasound Market Trends

MEA automated breast ultrasound market is anticipated to witness significant growth over the forecast period. This growth can be attributed to the growing public awareness of breast cancer prevention and treatment. Demographic shifts in the Middle East and Africa, such as urbanization and lifestyle changes, may also contribute to the growing demand for automated breast ultrasound, thereby increasing the market growth in this region. The UAE has a significant track record for accelerated approval of cancer drugs. For instance, in June 2026, the United Arab Emirates became the first country in the world to approve the new oral breast cancer drug Etcamah, which targets the ESR1 gene, and the government stressed its willingness to introduce innovative medicines and treatments more quickly.

Key Automated Breast Ultrasound Company Insights

Some of the key companies in the automated breast ultrasound industry include GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Canon Medical Systems Corporation, and others. These companies are growing their market revenue by launching new products, entering into collaborations, and adopting other strategies.

• Delphinus Medical Technologies, Inc. is a Novi, Michigan-based company dealing with automated breast ultrasound, offering advanced solutions for dense breast screening. It aims to help in the early detection of breast cancer and deliver medical innovations to improve screening and detection.
• GE HealthCare is a global medical technology company that engages in the manufacturing and distribution of diagnostic imaging and clinical systems. The company developed the Invenia Automated Breast Ultrasound (ABUS) system, which helps in enhanced breast cancer detection, particularly in women with dense breast tissue.

Key Automated Breast Ultrasound Companies

The following key companies have been profiled for this study on the automated breast ultrasound market:

• GE HealthCare

• Koninklijke Philips N.V.

• Siemens Healthcare Private Limited

• CANON MEDICAL SYSTEMS CORPORATION

• TELEMED Medical Systems srl

• Hologic, Inc.

• SuperSonic Imagine

• Lunit Inc.

• Delphinus Medical Technologies, Inc.

Recent Developments

• In January 2026, iSono Health announced the commercial launch of ATUSA, an FDA-cleared wearable and automated 3D quantitative breast ultrasound platform. The system was developed to expand access to portable, quantitative breast ultrasound imaging across outpatient clinics and community healthcare settings, reflecting the growing adoption of automated, accessible breast imaging technologies.
• In March 2025, GE HealthCare launched Invenia ABUS Premium, an automated breast ultrasound system equipped with Verisound AI, AI Assistant, and a Reverse Curve transducer. The platform was designed to improve image quality, workflow efficiency, and breast cancer screening for patients with dense breast tissue, highlighting continued advancements in AI-enabled automated breast ultrasound technologies.

Automated Breast Ultrasound Market Report Segmentation

This report forecasts revenue growth at global; regional; and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated breast ultrasound market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Automated Breast Volume Scanner

  • Automated Breast Ultrasound (ABUS)

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospital

  • Diagnostics Imaging Laboratories

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait